U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG,; Trademark Departmen |
---|---|
Address | Novartis Pharma AG,; Trademark Departmen Postfach CH-4002 Basel SWITZERLAND,, |
Date | Description | Action Tags | Code |
---|---|---|---|
Aug-21-2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | DENCO | |
Aug-21-2023 | DEATH OF INTERNATIONAL REGISTRATION | DETHP | |
May-13-2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | INNAR | |
Feb-17-2020 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | INPRP | |
Aug-23-2019 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Jun-04-2019 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | CORRI | |
Jun-04-2019 | CORRECTION UNDER SECTION 7 ¿ PROCESSED | COC.O | |
Jun-04-2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | APREA | |
Jun-03-2019 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Jun-03-2019 | FINAL DISPOSITION PROCESSED | FIMPP | |
Oct-04-2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Sep-04-2018 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Aug-10-2018 | CORRECTION TRANSACTION RECEIVED FROM IB | CRCVM | |
Jun-19-2018 | PUBLISHED FOR OPPOSITION | PUBOA | |
May-30-2018 | NOTICE OF PUBLICATION | NPUBO | |
May-15-2018 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
May-11-2018 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
May-10-2018 | ASSIGNED TO EXAMINER | DOCKD | |
May-09-2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
May-04-2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
May-03-2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM |